Filter
8+2+1 plus what? How UK data and market exclusivity rights will be affected from 1 January 2021
Biologics and biosimilars litigation update
SPC for ezetimibe/simvastatin considered invalid in preliminary relief proceedings
Targeted treatments – Part 3: the power of orphan drug protection
German Federal Court of Justice invalidates Truvada SPC
Targeted treatments – Part 1: Targeted treatments: patents for particular populations
Adrian Toutoungi, Josef Fuss and Matt Caskie discuss how biotech has managed its finances during the pandemic
Biologics and biosimilars litigation update
Return to work: key issues for life sciences